• Composition

- Tafluprost 0.015 mg

• Indications
• Reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension.
• As monotherapy in patients:
• Who would benefit from preservative free eye drops.
• Insufficiently responsive to first line therapy.
• Intolerant or contra-indicated to first line therapy.
• As adjunctive therapy to beta-blockers.

Dosage

• The recommended dose is one drop of TAFLUPRO in the conjunctival sac of the affected eye(s) once daily in the evening.
• Volume

6 plastic strips each of 5 (LDPE) plastic single dose units, each unit contains 0.3 ml ophthalmic solution.